Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 10,000 shares at $22.35 ($224K) on 2021-06-29, disclosed to the SEC on 2021-06-30.
Open-market sale of $224k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |
| GTHX | SELL | 2018-12-04 | $782K | — | Filing → |